Published Medical Controlled Delivery of Agonist It shows significant synergy leading to an enhanced activation of two subsets of Dendritic cells, inducing T-cell response at the tumor site in an aggressive melanoma cancer model. By Harvard University
Published Medical Inflammatory & Autoimmune Parenteral administration of TCT suppressed the induction of T cells responses directed by dendritic cells in vitro and by direct administration with antigens in vivo. By Trinity College Dublin
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
